Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Expression of stromal genes associated with the angiogenic response are not differentiated between human tumour xenografts with divergent vascular morphologies.

Farren M, Weston S, Brown H, Broadbent N, Powell S, Shaw R, Smith NR, Inglis R, Graham A, Ashton S, Wedge SR, Barry ST.

Angiogenesis. 2012 Dec;15(4):555-68. doi: 10.1007/s10456-012-9280-2. Epub 2012 May 27.

PMID:
22644562
2.

Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.

Bockhorn M, Tsuzuki Y, Xu L, Frilling A, Broelsch CE, Fukumura D.

Clin Cancer Res. 2003 Sep 15;9(11):4221-6.

3.

The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.

Gunningham SP, Currie MJ, Morrin HR, Tan EY, Turley H, Dachs GU, Watson AI, Frampton C, Robinson BA, Fox SB.

J Pathol. 2007 Jul;212(3):335-44.

PMID:
17487938
4.

An improved procedure to quantify tumour vascularity using true colour image analysis. Comparison with the manual hot-spot procedure in a human melanoma xenograft model.

van der Laak JA, Westphal JR, Schalkwijk LJ, Pahlplatz MM, Ruiter DJ, de Waal RM, de Wilde PC.

J Pathol. 1998 Feb;184(2):136-43.

PMID:
9602703
5.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
6.

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.

Koukourakis MI, Giatromanolaki A, Kakolyris S, O'Byrne KJ, Apostolikas N, Skarlatos J, Gatter KC, Harris AL.

Br J Cancer. 1998 May;77(10):1696-703.

7.

Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.

van Kempen LC, Leenders WP.

Eur J Cell Biol. 2006 Feb;85(2):61-8. Epub 2005 Nov 11. Review.

PMID:
16439306
8.

Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model.

Tahtis K, Lee FT, Wheatley JM, Garin-Chesa P, Park JE, Smyth FE, Obata Y, Stockert E, Hall CM, Old LJ, Rettig WJ, Scott AM.

Mol Cancer Ther. 2003 Aug;2(8):729-37.

9.

Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis.

Claffey KP, Abrams K, Shih SC, Brown LF, Mullen A, Keough M.

Lab Invest. 2001 Jan;81(1):61-75.

PMID:
11204275
10.

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.

Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G.

Cancer Res. 2003 Jun 15;63(12):3403-12.

11.

Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.

Yang F, Strand DW, Rowley DR.

Oncogene. 2008 Jan 17;27(4):450-9. Epub 2007 Jul 16.

PMID:
17637743
12.

Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.

Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR.

Cancer Res. 2002 Jun 1;62(11):3298-307.

13.

Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma.

González-Vela MC, Garijo MF, Fernández F, Buelta L, Val-Bernal JF.

Histopathology. 1999 Jan;34(1):35-42.

PMID:
9934582
14.

Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.

McAlhany SJ, Ressler SJ, Larsen M, Tuxhorn JA, Yang F, Dang TD, Rowley DR.

Cancer Res. 2003 Sep 15;63(18):5859-65.

15.
16.

Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.

Davidson B, Reich R, Kopolovic J, Berner A, Nesland JM, Kristensen GB, Tropé CG, Bryne M, Risberg B, van de Putte G, Goldberg I.

Clin Exp Metastasis. 2002;19(2):135-44.

PMID:
11964077
17.

Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line.

Biroccio A, Candiloro A, Mottolese M, Sapora O, Albini A, Zupi G, Del Bufalo D.

FASEB J. 2000 Apr;14(5):652-60.

PMID:
10744622
18.

CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation.

Poliani PL, Mitola S, Ravanini M, Ferrari-Toninelli G, D'Ippolito C, Notarangelo LD, Bercich L, Wagener C, Memo M, Presta M, Facchetti F.

J Pathol. 2007 Apr;211(5):541-9.

PMID:
17310502
20.

Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours.

Azoitei N, Pusapati GV, Kleger A, Möller P, Küfer R, Genze F, Wagner M, van Lint J, Carmeliet P, Adler G, Seufferlein T.

Gut. 2010 Oct;59(10):1316-30. doi: 10.1136/gut.2009.206813. Epub 2010 Aug 23.

PMID:
20732914

Supplemental Content

Support Center